PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript
Good day, and thank you for standing by. Welcome to today's conference call CHMP opinion on Translarna.
(Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your host today, Ron Aldridge, Senior Director, Investor Relations. Please go ahead.
Good morning, and thank you for joining us today to discuss the CHMP opinion on Translarna. I'm joined today by our Chief Executive Officer, Dr. Matthew Klein.
Today's call will include forward-looking statements based on our current expectations, including with respect to PTC's plans for interactions with the European Medicines Agency and the outcome of any reexamination process. Please take a moment to review the press release that we issued this morning, which contains more information regarding forward-looking statements.
Our actual results could materially differ from these forward-looking statements, as such statements are subject to risks that can materially and adversely affect our business
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |